5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Rectal cancer
- Focus Therapeutic Use
- 14 Jun 2013 Status changed from active, no longer recruiting to discontinued according to results presented at ASCO 2013.
- 05 Jun 2009 Interim results reported at the 45th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2009 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History